Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 3:11:616766.
doi: 10.3389/fendo.2020.616766. eCollection 2020.

Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS

Affiliations
Review

Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS

Martina Capuzzo et al. Front Endocrinol (Lausanne). .

Abstract

Since the historical use of gonadotrophin and estradiol levels to define the different anovulatory disorders has shown some limitations, the use of other markers such as anti-müllerian hormone (AMH) has been proposed. This review addresses the role of AMH in the differential diagnosis of anovulatory disorders, especially focusing on its value in the prognostic characterization of their severity. Current limitations and future clinical applications are discussed.

Keywords: amenorrhea; anovulatory disorders; anti-Müllerian hormone; polycystic ovary syndrome; premature ovarian insufficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Anovulatory infertility. The ESHRE Capri Workshop Group. Hum Reprod (1995) 10(6):1549–53. - PubMed
    1. Lie Fong S, Schipper I, Valkenburg O, de Jong FH, Visser JA, Laven JS. The role of anti-Müllerian hormone in the classification of anovulatory infertility. Eur J Obstet Gynecol Reprod Biol (2015) 186:75–9. 10.1016/j.ejogrb.2015.01.007 - DOI - PubMed
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 19(1):41–7. 10.1093/humrep/deh098 - DOI - PubMed
    1. European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod (2016) 31(5):926–37. 10.1093/humrep/dew027 - DOI - PubMed
    1. Sacchi S, D’Ippolito G, Sena P, Marsella T, Tagliasacchi D, Maggi E, et al. The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH. J Assist Reprod Genet (2016) 33(1):95–100. 10.1007/s10815-015-0615-y - DOI - PMC - PubMed

Substances